Non-Standard Therapies Used in 20% of Localized High-Risk PCa Cases
Using EBRT alone or ADT alone for high-risk localized prostate cancer is associated with worse survival outcomes.
Radiotherapy
Primary Tumor Irradiation May Improve Survival in mCRPC
In a study, radiation delivered to the primary prostate tumor in men with metastatic castration-resistant prostate cancer was associated with a 74% decreased risk of death from any cause.
Prostate Cancer Mortality Lowest With Radical Prostatectomy
In a study with a follow-up period of 18 years, men treated with any other modality but radical prostatectomy had higher prostate cancer death risks.
Metastatic Prostate Cancer Responds to Novel Radiation Therapy
By targeting prostate-specific membrane antigen, a molecule radiolabeled with lutetium-177 is expected to deliver high doses of beta radiation to distant metastases.
Younger Men With High-Grade PCa Less Likely to Die After RP Than RT
Patients younger than age 60 with Gleason 8-10 disease who had upfront surgery versus radiation therapy had a 63% lower risk of prostate cancer-specific mortality.
Hypofractionated Radiotherapy May Benefit Patients With Localized Prostate Cancer
A study suggests HIMRT may have some advantages over CIMRT for treating men with localized prostate cancer.
Hypofractionated Radiation OK for Localized Prostate Cancer
New multidisciplinary guideline for early-stage prostate cancer developed by 3 professional societies.
Radiation Ups Survival When PCa Metastatic Burden Is Low
The 3-year survival rate was 81% for patients who underwent EBRT plus standard care vs 73% for those who had standard care alone.
Long-Term Benefit for Stereotactic Radiation in Prostate Cancer
Trials show high survival rates, freedom from recurrence for low-, intermediate-risk prostate cancer.
Light Use of Topical Skin Tx Before Radiotherapy Seems Safe
Radiation dose not impacted with light or moderate use of skin treatments, regardless of beam energy, incidence
Next post in Urology
